TALOPH(SH:600222) Shang Hai Zheng Quan Bao·2025-05-15 19:30Core Viewpoint - The announcement details that the wholly-owned subsidiary Tongjuntang Pharmaceutical Co., Ltd. has provided a guarantee for the parent company Henan Tailong Pharmaceutical Co., Ltd. to secure a credit facility from China Everbright Bank, with a maximum amount of RMB 120 million [3][4]. Group 1: Guarantee Details - The guarantor is Tongjuntang Pharmaceutical Co., Ltd., a wholly-owned subsidiary of the company [3]. - The maximum guarantee amount provided is RMB 120 million, which has already been fully utilized as of the announcement date [3][4]. - There is no counter-guarantee for this transaction [4]. Group 2: Company Background - Henan Tailong Pharmaceutical Co., Ltd. was established on August 31, 1998, and has a registered capital of RMB 573.886283 million [6][7]. - The company operates in the pharmaceutical production and sales sector, among other activities [7]. - Major shareholders include Zhengzhou Tairong Industrial Investment Co., Ltd. with 14.37% and Zhengzhou Zhongsheng Industrial Group Co., Ltd. with 8.71% [7]. Group 3: Financial and Operational Context - The company has a total external guarantee balance of RMB 252.3896 million, which represents 16.03% of the latest audited net assets [8]. - The guarantee is intended to support the company's operational funding needs and enhance its financing capabilities [8].